We are live on ! Find out more
IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Delisted

IMUC was delisted on the 16th of October, 2018.

17 hedge funds and large institutions have $293K invested in ImmunoCellular Therapeutics, Ltd. in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 1817 (-1)

16% less capital invested

Capital invested by funds: $348K → $293K (-$55K)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change